Efficacy of sacituzumab govitecan (anti-Trop-2-SN-38 antibody-drug conjugate) for treatment-refractory hormone-receptor positive (HR+)/HER2– metastatic breast cancer (mBC) - Bardia, A; Diamond, J R; Vahdat, L T (J Clin Oncol, 2018)
(Suppl.)